Regeneron pharmaceuticals, inc. sued for securities law violations - contact the gross law firm before march 10, 2025 to discuss your rights – regn

New york, feb. 03, 2025 (globe newswire) -- the gross law firm issues the following notice to shareholders of regeneron pharmaceuticals, inc. (nasdaq: regn).

REGN Ratings Summary

REGN Quant Ranking